Misplaced Pages

This is an old revision of this page, as edited by PaulWicks (talk | contribs) at 15:51, 13 September 2006 (+ Intro). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

It has been suggested that this article be merged into Parkinson's disease. (Discuss)

Non-motor symptoms in Parkinson's disease

Although the most obvious symptoms of Parkinson's affect movement, there is an increasing realisation in clinical practice that non-motor symptoms are at least as important in successful management. Accurate diagnosis is made difficult by the overlap between organic symptoms of Parkinson's disease and non-motor symptoms, and it is becoming clear that without the use of objective measures, underdiagnosis is likely to occur. For instance, a Parkinsonian individual with low energy, flat affect, and sexual dysfunction could easily be diagnosed as depressed. Improving treatment of non-motor symptoms such as sleep disturbance and hallucinations could significantly improve quality of life for this group.

Depression in Parkinson's Disease

Mood disturbances:

• depression: occurs in 40-80% of cases; 20% of depression cases are major depressive disorder; severity and persistence of depression is positively associated with executive dysfunction and dementia;

• anxiety or panic attacks
  Note: 70% of individuals with Parkinson's disease diagnosed with pre-existing depression go on to develop anxiety; 90% of Parkinson's disease patients with pre-existing anxiety subsequently develop depression);
• apathy or abulia: abulia translates from Greek as the absence or negative of will; apathy is an absence of feeling or desire

Cognitive disturbances:

• slowed reaction time; both voluntary and involuntary motor responses are significantly slowed.
• executive dysfunction, characterized by difficulties in: differential allocation of attention, impulse control, set shifting, prioritizing, evaluating the salience of ambient data, interpeting social cues, and subjective time awareness. This complex is present to some degree in most Parkinson's patients; it may progress to:
• dementia: a later development in approximately 20-40% of all patients, typically starting with slowing of thought and progressing to difficulties with abstract thought, memory, and behavioral regulation.
• memory loss; procedural memory is more impaired than declarative memory. Prompting elicits improved recall.
• medication effects: some of the above cognitive disturbances are improved by dopaminergic medications, while others are actually worsened

Sleep disturbances:

• Excessive daytime somnolence;
• Initial, intermediate, and terminal insomnia;
• Disturbances in REM sleep: disturbingly vivid dreams, and REM Sleep Disorder, characterized by acting out of dream content;

Sensation disturbances:

• impaired visual contrast sensitivity, spatial reasoning, colour discrimination, convergence insufficiency (characterized by double vision) and oculomotor control
• dizziness and fainting; usually attributable orthostatic hypotension, a failure of the autonomous nervous system to adjust blood pressure in response to changes in body position
• impaired proprioception (the awareness of bodily position in three-dimensional space)
• loss of sense of smell (anosmia),
• pain: neuropathic, muscle, joints, and tendons, attributable to tension, dystonia, rigidity, joint stiffness, and injuries associated with attempts at accommodation

Autonomic disturbances:

• oily skin and seborrheic dermatitis;
• urinary incontinence, typically in later disease progression
• constipation and gastricdysmotility: severe enough to endanger comfort and even health
• altered sexual function: characterized by profound impairment of sexual arousal, behavior, orgasm, and drive is found in mid and late parkinson disease. Current data addresses male sexual function almost exclusively.

References

1. Allain H (2000). "Depression in Parkinson's disease". BMJ. 320: 1287–1288. PMID 10807601.
2. Shulman LM (2000). "Non-recognition of depression and other non-motor symptoms in Parkinson's disease". Parkinsonism Relat Disord. 8 (3): 193–197. PMID 12039431.
3. Michael J Frank (2005). "Dynamic Dopamine Modulation in the Basal Ganglia: A Neurocomputational Account of Cognitive Deficits in Medicated and Non-mediacated Parkinsonism". Journal of Cognitive Neuroscience. 17: 51–73.